Research and Markets: Esophageal Cancer-Global API Manufacturers, Marketed and Phase III Drugs - Landscape for 2015

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/kg2l3b/esophageal) has announced the addition of the "Esophageal Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015" report to their offering.

Esophageal Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Esophageal Cancer. A key objective of The report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries.

The Report gives insights into patents providing thepatent protection data and marketing exclusivity of all the drugs across the Esophageal Cancer. While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

SCOPE:

  • A review of the marketed products under prescription for Esophageal Cancer, regulatory information and marketing status.
  • Coverage of global patent coverage and detailed commentaries on the US patent challenges.
  • Graphical representation of investigational products for patent expiry and market exclusivities across the globe.

Key Topics Covered:

  • Indication Overview
  • Marketed Drugs
  • Marketed Details of Drugs by Application Type
  • Marketed Details of Drugs (NDA) by Marketing Status
  • Marketed Details of Drugs by Patent Expiration Timeline
  • Active Pharmaceutical Ingredient (API) Manufacturers Assessment
  • API Manufacturers by United States Drug Master File (US DMF) Status
  • API Manufacturers by US DMF Status (Drug Specific)
  • API Manufacturers in Europe by Country
  • API Manufacturers in India by State
  • API Manufacturers in China by Province
  • Marketed Details of Approved Drugs by Geography
  • Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
  • API Manufacturers by US DMF Status (Drug Specific)
  • Drugs Market Data and Forecasted Sales Figure (2012-2016)
  • Marketed Drugs for Esophageal Cancer
  • Drug Name
  • Drug Description
  • Global Active Pharmaceutical Manufacturers for Drug
  • Approval Status of Drug
  • Patent and Exclusivity Details for Drug
  • Company Profile and Financials
  • Phase III Drugs
  • United States Drug Master File (DMF)
  • Discontinued Drugs

For more information visit http://www.researchandmarkets.com/research/kg2l3b/esophageal

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals